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More than twenty years ago, hydroxyapatite (HA), calcium phosphate ceramics, was introduced as a coating for cementless hip
prostheses. The choice of this ceramic is due to its composition being similar to organic apatite bone crystals. This ceramic is
biocompatible, bioactive, and osteoconductive. These qualities facilitate the primary stability and osseointegration of implants.
Our surgical experience includes the implantation of more than 4,000 cementless hydroxyapatite coated hip prostheses since 1990.
The models implanted are coated with HA in the acetabulum and in the metaphyseal area of the stem. The results corresponding
to survival and stability of implants were very satisfactory in the long-term. From our experience, HA-coated hip implants are a
reliable alternative which can achieve long term survival, provided that certain requirements are met: good design selection, sound
choice of bearing surfaces based on patient life expectancy, meticulous surgical technique, and indications based on adequate bone
quality.
1. Introduction
Since Charnley’s first design of low friction arthroplasty
which emerged in the 1960s [1] a number of improvements
have gradually arisen, affecting design, materials, primary
and secondary implant fixation systems, and biomechanical
and biological adaptations which occur in the bone after joint
replacement. The main objective in all instances has been
to improve the survival of the implant in the long term [2],
a goal shared by all surgeons. Implant to bone fixation was
initially achieved by means of acrylic cement, which was
also introduced by Charnley. Although long-term outcomes
of cemented hip arthroplasty have been good and modern
cementing techniques can improve implant survival even
further, cemented hip implants have always been a concern in
young and more active patients. Cementless hip arthroplasty
emerged at the end of the 1970s, as an alternative to cemented
systems. Primary fixation of cementless designs is based on
a tight press-fit of the implant into the bone, and secondary
or definitive fixation depends on a biological anchoring in
bone, needed to ensure long-term survival of the implant [3].
In early cementless designs biological fixation was poor, and
loosening was common. Primary bone-implant stability is
critical because although 50 to 150𝜇mwidemicromovements
still allow new bone formation [4–7], the greater the mag-
nitude of micromovements, the lower the amount of bone
formation. Thus, bone-implant anchorage could turn into a
fibrous tissue which leads to loosening.
In the late 1970s, porous coatings were added to implant
surfaces in order to improve osseointegration [8–12]; how-
ever, a high incidence of thigh pain, bead shedding, and loos-
ening was found. Implant osseointegration of these designs
took a long time, and surgical techniquewas demanding. Fur-
ther research on porous coatings [13] brought improvements
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in manufacturing which immediately improved clinical out-
comes.
The search for a type of coating capable of enhancing
implant osseointegration led to growing interest in calcium
phosphate ceramics, which were first used for coating dental
implants and then were brought into the orthopaedics field.
Hydroxyapatite (HA) was chosen from calcium phosphate
ceramics for its chemical characteristics and for being a
major component of bone mineral content. The Leiden
Biomaterials Research Group, Gloot and Geesing [14, 15],
Furlong [16], Manley [17], and Epinette [18] pioneered the
orthopaedic use of HA, as an osteoconductivematerial which
promotes osseointegration of implants improving their long-
term survival. Currently, HA-coated implants have been in
use for nearly 30 years with excellent results.
Hydroxyapatite: Structure and Properties. Synthetic calcium
phosphate ceramics have similar chemical and crystalline
properties to biological apatite crystals. Among them, the
HA (Ca
10
(PO
4
)
6
(OH)
2
) is the most similar to biological
apatite crystals, but its atomic ratio is 1.67 times greater than
that of bone or dentine, and it is the least soluble of all
calcium phosphate ceramics [19]. HA is biocompatible (it
does not cause toxic or inflammatory responses in vivo) [20],
bioactive, and osteoconductive, but HA is not osteoinductive
[19]. Its mechanical characteristics include high compressive
strength (700MPa) but low tensile (250MPa) and fatigue
strength [21]. HA is used for creating a coating on prosthetic
cup or stem surfaces, which are usually made of a titanium
alloy (TiAlV). HA deposition is often achieved through
the plasmaspray technique, which is performed at high
temperature (15000∘) and under vacuum, by projecting HA
particles onto the metallic material at a speed of 300m/s.The
metallic substrate has a rough surface to promote adhesion.
The other manufacturing method achieves HA deposition
by electrochemical means, although it appears that the
plasma spray technique is associated with improved bone
ongrowth [22]. Advisable HA coating thickness is 50 𝜇m
because coats 15–20𝜇m thick are quickly dissolved, and coats
100–150𝜇m thick may suffer delamination as a result of
the tensile forces produced in uploading [21], even though
good results have been reported with thicker (200 microns)
coatings [16]. HA coating should have pores of about 100–
200 microns and an acceptable porosity index to promote
osteoconductivity, although coating strength decreases with
porosity [19]. Another key characteristic of HA coating is
crystallinity, which is associated with increased bioactiv-
ity and bone growth and with decreased bone resorption
[23].
Other important matters are the HA coating resorption
after implantation, or the coating delamination process, most
likely in thicker coatings (150–200 microns) and unstable
implants [24].
No strong evidence can be found in literature about the
HA resorption process and loss of HA coating. However, two
phases in HA loss have been suggested [25]. The first one,
in the immediate postoperative period, is when micromove-
ments in the HA-bone interface lead to the formation of a
fibrous membrane with high metabolic activity, containing
fibroblasts andmacrophages which are able to remove theHA
coating. This inflammatory response, described as transient
by Geesink et al. [21], along with an increased fluid content
and a low pH, helps to dissolve the less crystalline HA, releas-
ing calcium ions which may have biological activity [19].
These calcium ions can be incorporated into the remaining
HA coating, increasing its crystallinity and thus reducing the
subsequent coating loss, which takes years to disappear [26].
The bone around the implant is also undergoing a remodeling
process, adaptive remodeling, regulated by biomechanical
changes, among other factors. Osteoclastic activity linked to
adaptative remodeling contributes to HA resorption [19, 26–
31], which is related to the thickness of the coating layer [28].
Later the lost HA coating is replaced by new bone [26–31]
leading to implant osseointegration. New bone apposition on
the HA coating surface begins at third postoperative week
[21, 32–34], and initially it has a lamellar structure which is
gradually replaced by a Haversian structure as remodeling
progresses [21].
2. Materials and Methods
In 1990 our department started using cementless HA-coated
hip implants, in particular the ABG I prosthesis (Stryker).
It consists of an anatomical HA-coated stem with press-fit
metaphyseal fixation and an HA-coated hemispherical cup.
TheABG I implant ismade of a titaniumalloy (Ti6Al4V)with
Young’s modulus of 110GPa (Figure 1(a)). The HA coating,
applied through a plasma spraying process, was 50 𝜇m thick
and of about 80% crystallinity after the manufacturing
process. Until September 1999, this design was implanted in
1637 patients (bilateral in 277 of them), with a total of 1914
hip arthroplasties. The bearing surfaces were conventional
polyethylenewithmetal or zirconia heads in all cases. In 1999,
the ABG I system was replaced by a new design, the ABG II
model (Figure 1(b)). The new cup has only five holes through
which spikes or screws can be inserted for proper primary
fixation, and hole plugs are supplied for sealing unused holes.
The “shoulder” of the stem is higher and its metaphyseal
region has a decreased volume.The diaphyseal portion of the
stem also has a smaller diameter and length and is highly
polished. Titanium alloy was improved with the addition
of molybdenum, zirconium, and ferrous (iron), reducing
Young’smodulus to 74–85GPa.HA coating,manufactured by
a Stryker patented process, keeps the same coating thickness
but crystallinity has been improved to 98%. Highly cross-
linked polyethylene (Duration) liners with metallic or zir-
conium heads and ceramic on ceramic heads were used as
bearing couplings. From September 1999 to December 2013,
1694 patients were operated on; 428 of them were bilateral,
bringing the number to 2122 total hip arthroplasties.
A similar surgical technique was used in both ABG
models, and only the surgical instruments for acetabular and
femoral preparation varied somewhat between them. The
same posterolateral approach, intravenous antibiotic prophy-
laxis (2nd generation cephalosporins), and antithrombotic
prophylaxis protocol (low molecular weight heparin) were
used in all cases. Over the years, the only significant changes
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Figure 1: (a) ABG-I stem and acetabular cups; (b) ABG-II stem and
acetabular cup.
in postoperative management have been a shorter postoper-
ative immobilization and a reduced length in hospital stay.
Regardless of our participation in an international mul-
ticenter follow-up study on ABG I outcomes [35], several
long-term follow-up studies have been carried out in our
department.
A ten-year follow-up study, on 630ABG I prostheses
implanted in 579 patients, was reported [36]. Clinical out-
comes were assessed with the Merle D’Aubigne-Postel score
[37], and bone was quality scored, on plain preoperative
radiographs, according to the modified Singh scale [38].
Different radiographic items were evaluated at the first, fifth,
and tenth postoperative years. Description of radiological
findings was done according to the Gruen zones [39] in
proximal femur and De Lee and Charnley zones [40] in
periacetabular bone. Broker scale for heterotopic ossifications
was used [41]. Polyethylene wear was assessed with the
Livermore method [42], and granulomatous and osteolytic
lesions, secondary to wear debris particles, were also exam-
ined. Position of the cup in relation to the anatomic hip
rotation centre, cup inclination (opening) angle, and size of
the stem in relation to the diameter of the femur were studied
too.
On the other hand, 196ABG II arthroplasties, implanted
in 168 patients, were followed up for a mean of 11.3 years [43].
In this case, clinical outcomes were assessed with Harris hip
score [44] and subjective outcomes with the EuroQolGroup
EQ-5D questionnaire [45]. The Livermore method [42]
was used again to evaluate polyethylene wear, even though
evaluation was done by means of a computer program since
digital radiology had become available. Granulomatous and
osteolytic lesions were measured, in this case, according to
the scale proposed by Goetz et al. [46].
Both in the ABG I and in the ABG II studies, a statistical
𝜒
2 analysis for categorical data and percentages comparison
and a Student’s 𝑡-test for means comparison of isolated data
or between pairs of related data with Pearson correlationwere
used. The level of significance was set at 𝑃 < .05.
To assess the femoral remodeling changes which occur
after stem implantation, a group of patients with ABG
I implants had DXA exams which were recorded in the
preoperative and throughout the follow-up period (15th
day, 3rd, 6th, and 12th month, and annually until the 10th
postoperative year) [47]. Similarly, another group of patients
with ABG II implants hadDXA exams throughout a five-year
follow-up period [48].
Finally, simulations were made with the ABG I and ABG
II stems, by means of the finite element method, to assess the
biomechanical changes which occur in the femur after stem
implantation. Simulation results were compared with their
respective DXA studies in each model [49–51].
3. Results
The gender distribution in the ABG I group was 55.39%male,
with a mean age of 58.10 years, and 44.61% female, with a
mean age of 61.32 years. In the ABG II group, 70.83% were
men and 29.17% were women, and the mean age was 11.26 ±
58.84 years (SD) with a range of 23–77 years.
Clinical outcomes in each implant group are specified
below: in the ABG I group the mean preoperative Merle
D’Aubigne-Postel score was 7.91, and it increased to 16.21
(range 9–18) at the 10th year; subjective assessment was
excellent or good in 82.1% of cases. In the ABG II group,
the mean preoperative Harris hip score was 32.55, and the
average postoperative score rose to 85.80 (range 26.05–95.82);
subjective assessment was excellent or good in 90.32% of
cases.
ABG I implants survival at 10-year follow-up was 97.1%.
Although all acetabular components were stable, 1.35% of
these patients needed revision surgery because of an excessive
polyethylene wear. In these cases, the liner was replaced
by a highly cross-linked polyethylene, and femoral and/or
periacetabular osteolytic lesions were cleaned and grafted.
But the prosthetic cup remained stable in all cases and was
not replaced.
At 17-year follow-up with ABG I, 18 patients needed revi-
sion surgery for major acetabular and/or femoral osteolytic
lesions. In such cases both the stem and the cup remained
stable; therefore only polyethylene liner was replaced and
osteolytic lesions were curetted and grafted. At 20-year
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Figure 2: X-ray image of patient with follow-up at 12 y. Osteolysis
in acetabulum produced by excessive polyethylene wear.
Figure 3: Computed tomography of the same case in Figure 2.
Osteolysis in acetabulum.
follow-up, 21 patients needed revision surgery for major
acetabular and/or femoral osteolytic lesions. Only in three
patients a replacement of the acetabular cup and femoral
stem was performed, implanting a cemented prosthesis in
all of them. In the remaining 18 the implants were stable
despite osteolytic lesions; therefore only polyethylene liner
was replaced and osteolytic lesions were curetted and grafted
(Figures 2 to 5).
ABG II prosthesis survival at a mean of 11.3 years of
follow-up was 98.30%, with all acetabular components being
stable and with no signs of migration.
The key difference between the two model outcomes
is polyethylene wear. Duration polyethylene, used in the
ABG II model, has shown a 54.55% less wear rate than
conventional polyethylene used in the ABG I model. The
ABG I polyethylene wear has been greatest in acetabular cups
placed in a low position (𝑃 = .038), with opening angles
greater than 46∘, and in patients under the age of 65.
At ten years of follow-up, the incidence of periacetabular
Figure 4: X-ray control of patient in Figures 2 and 3, after 4 y follow-
up, after changing polyethylene and fulfilling with bone graft the
acetabulum osteolysis. No change of original implant.
Figure 5: Same case as in Figures 2, 3, and 4. X-ray control image
in 2013, after 8 y. follow-up of second surgery with original implant
since 1993.
granulomatous lesions in the ABG I group was 44.23% in
zone I, 37.11% in zone II, and 15% in zone III; and it was
78% in Gruen zone I and 91.73% in Gruen zone 7. Despite
this, all the acetabular and femoral components were stable,
even though some stems showed some subsidence. In the
ABG II group, granulomatous lesions were very small and
only occurred in metal on polyethylene or zirconium on
polyethylene couplings. In this group, 9.52% of cases showed
osteolytic lesions in acetabular zone I and 12.7% in Gruen
zones 1 and 7. Decreased incidence of osteolytic lesions in
the ABG II model is due to the lesser wear of the new
polyethylene but, in our opinion, the sealing of unused cup
holes may also have played a role.
Stem subsidence has been evaluated in both models and
significant differences have been found. In the ABG I group,
of the cases in which the size of the stem was deemed
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appropriate, mean subsidence was 1.51mm at the first year
and increased to 3mm at the 10th year. However, when
the size of the stem was deemed large, mean subsidence
was 2.29mm at the first year and reaches 4.17mm at the
10th year. In the ABG II group, lesser subsidence has been
found among the cases in which the size of the stem was
deemed appropriate; mean subsidence at the first year was
0.514mm and rose to 0.638 ± 0.180 (SD) at the end of follow-
up, but oversized stems showed 2.435mm and 2.830mm,
respectively. In both studies oversized stems were associated
with a significantly greater subsidence (𝑃 = .0001).
Femoral remodeling has also shown to be significantly
different between the two groups. Up to 90% of cases in the
ABG I group showed evident bone devitalization in Gruen
zones 1 and 7, while bone loss was less marked in the ABG
II group in which it was only detected in 42.07% of cases.
Cancellous bone densification in zones 2 and 6 of Gruen
was present in 89.42% and 83.26% of cases in the ABG I
group, respectively, while in the ABG II group this finding
was detected in zone 2 in 34.43% of cases and in zone 6 in
29%of cases. Cancellous bone densification is associatedwith
larger stems (𝑃 = .002). The high rates of devitalized bone in
zones 1 and 7 are caused by the stress-shielding effect which
occurs after insertion of a femoral stem. Stress-shielding in
femoral zones 1 and 7 is strongly associated with females
(𝑃 = .001), older age (𝑃 = .001), and low preoperative Singh
index (𝑃 = .001) in both stem models. Comparisons of DXA
studies at five-year follow-up show a 13.07% bone loss in zone
1 and 37.5% in zone 7 in the ABG I group, while in the ABG
II group the results are 9.07% in zone 1 and 23.88% in zone 7
(Figure 6). These data may mean that design changes in the
ABG II stem have achieved a better load transmission.
4. Discussion
Our 23 years of experience in routine use of HA-coated
hip prostheses is quite satisfactory as regards the long-
term stability of implants, in agreement with Geesink [52].
Primary implant stability is favored by HA coating, which
provides improved contact between bone and implant [26,
52–56], and osteointegration of HA-coated implants has been
sufficiently demonstrated in many studies [26–31, 33, 34].
Through the years, as resorption of the HA coating is caused
by chemical dissolution or osteoclastic action, new bone
formation replaces it in a percentage which could rise to 78%,
according to a number of publications [26, 27, 30, 31, 33,
57]. It is clear, however, that HA-coated implants achieve a
stable fixation despite osseointegration not being complete.
Moreover, it is well documented that HA debris particles
cause no osteolytic reaction [21, 28, 30, 57]. In our personal
experience no osteolytic reaction was detected along more
than 23 years.
The most important problem we have experienced with
the ABG I model is excessive wear of conventional polyethy-
lene and subsequent periprosthetic osteolysis (Figures 7 and
8), although fortunately implants remained stable at 20 years
of follow-up. Concerning the ABG II model, with Duration
highly crosslinked polyethylene, it has shown much lower
wear rates and osteolityc lesions have been significantly less
frequent.We believe that sealing unused cup holes has limited
the migration of wear debris to acetabular bone, helping to
reduce the incidence of osteolytic acetabular lesions. Good
peripheral osseointegration of the cup could also have acted
as a barrier towear debrismigration [58].The lower incidence
of osteolytic lesions that we have also found in the femur can
be explained by the reduced rate of wear debris particles in
the ABG II model. But in addition, changes in design of the
stem and improved HA crystallinity could have played a role
in enhanced osseointegration, which would prevent debris
migration into the femoral implant-bone interface [59].
Concerning loads acting on the hip, there are previous
works [60, 61] that include a comparative analysis for different
combinations of muscle loads, concluding that the more
appropriate cases are those that consider the load comprising
gluteus medius, iliotibial tract, and psoas iliacus, or only the
action from abductor muscle, which produce compression
in the femur. For the simulations carried out by our group,
the last option was chosen in accordance with the majority
of authors [62–65]. Orthoload’s database values were used to
apply hip reaction forces at the head of the stem and abductor,
respectively [66].
Hip arthroplasty modifies the initial tensional state of the
hip joint. In the healthy femur, loads are transferred from
the femoral head to the lesser trochanter which distributes
the compressive forces to the femoral diaphysis [30]. Load
distribution can explain the anatomical structure of the pri-
mary trabecular bundles of the healthy femur: the arch shape,
formed by traction forces, and the principal compression
group of Delbet, formed by compression forces [31]. Despite
this load pattern is inverted after hip replacement, so that
the stresses are transferred fundamentally from the prosthetic
head to the stem, which transmits mechanical loads to the
zone of the femur corresponding with the end of stem
HA coating. Thus, a bottleneck effect is produced, as was
demonstrated in the simulation (Figure 9), which leads to
stress-shielding. Due to these changes in the transmission of
forces all implants cause remodeling changes in the proximal
femur, though cemented stems do it to a lesser extent
[67]. Adaptative remodeling is due to an alteration in loads
transmission produced by the femoral stem. It is regulated by
Wolf ’s Law [67, 68] and is a multifactorial process influenced
by the bone quality and stiffness, implant design and stiffness,
type of bone fixation, and forces acting on the femur [64,
69–75]. As Huiskes et al. [68] pointed out, preoperative
bone mass of the proximal femur is a very important factor
in adaptative remodeling. ABG stems theoretically have a
metaphyseal anchorage and, like other similar designs, were
intended to transmit loads from proximal to distal femur
and avoid stress-shielding. But so far, this goal has not been
achieved as McAuley et al. [76] demonstrated. Loads are
mostly transmitted through the distal end of the metaphyseal
bone, right where stem coating ends. Lack of loading on
the proximal femur is a common problem to all anatomical
stem designs [77–79]. The biomechanical finite element (FE)
studies we have conducted on both ABG stems [49–51]
support this assertion (Figure 9). The highest incidence of
cancellous bone densification and cortical bone sclerosis
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Figure 6: Evolution of bone mass density for ABG I (blue) and ABG II (red), corresponding to five-year follow-up, in the Gruen zones.
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Figure 7: X-ray image of patient with follow-up at 12 y. Excessive
polyethylene wear. Osteolysis in metaphyseal of femur.
Figure 8: Same case as in Figure 7, after changing polyethylene and
fulfilling with bone graft and femoral mesh. No change of original
implant. Control at 20 y. of primary surgery.
detected in zones 2 and 6 of Gruen, in oversized stems, is
explained by the tight fit of the implant into the medullary
canal, which causes higher stresses in these zones (Figure 10).
Correlation between the data obtained from finite ele-
ment simulations and those obtained from DXA with ABG
I at 10 years [47] and ABG II at 5 years [48] shows that the
ABG-II stem ismore effective than theABG-Imodel, because
the former generates higher tensional values on femoral
bone, resulting in lesser bone loss (Figure 6).Thus, improved
loads transmissionmatches biological findings obtained with
DXA. We believe that the design and the alloy of stem have
major importance in the transmission of loads in the femur.
Changes in the lateral metaphyseal area and shoulder of
the ABG II with a more trapezoidal (tapered) design have
possibly contributed to improving the transmission, which is
in accordance with the experience of Leali and Fetto with a
lateral flare stem [80].
On the other hand, the lower length and volume of
the ABG II stem allow us to better preserve the cancellous
bone in the proximal femur which is an important factor for
adaptive remodeling after implanting a femoral stem [67].
The decrease in volume of the metaphyseal area of stem
ABG II has not affected the primary and secondary stability
thereof, as shown by the values of mean subsidence in ABG
II rods, which are 78.73% lower than the corresponding
to the ABG I stem, confirming the effectiveness of design
changes.
Adaptative remodeling and loads transmission influence
the replacement of HA coating by new bone. Osseointe-
gration rate is higher in heaviest loaded areas according
to Wolf ’s law [26], which is supported by our findings:
increased osseointegration in the metaphyseal-diaphyseal
transition area and persistence of HA coating in the proximal
metaphyseal area for more than 8 years after implantation of
the stem [31].
A good preoperative planning [79] and meticulous sur-
gical technique is needed in cementless hip arthroplasty to
achieve a perfect press-fit of implants which provides an
adequate primary fixation. Acetabular reamingmust progress
carefully down to bleeding subchondral bone, which is essen-
tial for secondary fixation, that is, osseointegration [81]. A
similar technique should be used in femoral preparation.HA-
coated implants require the same careful technique because
HA coating does not solve technical errors. Critical analysis
of our experience makes us understand that we have made
incorrect indications in older patients with poor bone quality,
who required oversized stems resulting in significant subsi-
dence.Therefore, we reaffirm that appropriate indication and
preoperative planning are essential requirements for good
outcomes. Although design improvements in the ABG II
stem have led to a decreased incidence of stress-shielding and
subsidence, we have to bear in mind that bone mass index
is critical to minimize stress-shielding, as Huiskes et al. [68]
noted. The new Duration polyethylene has decreased wear
by 54.55% compared to the conventional one, but alternative
bearing surfaces should be considered in young patients
with more demanding physical activity (ceramic-ceramic,
in which we observed no measurable wear over an 11-year
follow-up period).
Our HA-coated hip implants series has high long-term
survival, in line with other author series [34, 59, 77, 82–
96]. The excellent stability of HA-coated implants has been
demonstrated even in elderly patients [97]. Other studies find
no advantage in HA-coated implants over metallic-coated
designs, mainly in the acetabular cups [98–104]. Some even
believe that HA coating is a risk factor which contributes
to loosening and is associated with poor long-term results
in acetabular cups [105] in the HA coating stems, finding
no advantage over metallic-coated implants [106]. We think
it is risky attributing the mobilization of acetabular cups
only to the possible delamination of the HA, and the con-
sequent release of particles, when it coexists with excessive
polyethylenewear in these cases, whichwe consider primarily
responsible for osteolytic lesions. In our experience with the
ABG I prosthesis, which presents an excessive polyethylene
wear, 21 patients with 20-year follow-up needed major revi-
sion surgery for acetabular and/or femoral osteolytic lesions.
The replacement of the acetabular cup and femoral stem
was performed only in three patients; the rest had perfect
stability of their implants, demonstrating the advantages of
HA coating for reaching an excellent osseointegration. The
data of Danish Hip Arthroplasty Registry show excellent
8 BioMed Research International
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Figure 9: Maximum and minimum principal stress flow in the models with prosthesis (from a FE simulation).
B
A
Figure 10: X-ray image of oversized stem in right femur with
cancellous bone densification in support area (zone A) and bone
resorption (zone B).
medium-term survival of HA-coated and non-HA-coated
implants [107] and the data of the Finnish Arthroplasty
Register showed a better survival of HA-coated implants in
young patients [108]; the Norwegian Arthroplasty Register
showed that one brand of HA-coated stem had better survival
than some non-HA-coated components [109]. Our wide and
long-term experience in HA-coated hip implants and our
outcome with excellent survival go against these assertions,
in agreement with many authors [34, 59, 77, 82–96], but HA
is not a magic powder [89] and the indication and surgical
technique must be careful and correct in the HA-coated
prostheses.
The survival of HA coated acetabular cups is better than
of cemented cups especially in younger people which have
a high percentage of long-term loosening, while the long-
term survival of cemented stems reaches 85–95% according
to papers published, depending on follow-up time, cement-
ing techniques, and patient age [107–118]. Our personal
experience with cemented hip prosthesis has similar sur-
vival rates. Survival of cementless HA-coated prostheses is
superior in the acetabular components to the published
results of cemented prostheses [59, 77, 83–91] and it is
comparable in the femoral stems. Moreover if in the long
term it is necessary to perform a replacement this will
be technically easier in cementless prostheses because we
will have more bone stock for future revision surgery,
considering that today hip arthroplasties are implanted at
very young patients with high functional demands [119–
121] that possibly will need in the long term this type of
surgery.
In conclusion, HA-coated hip implants are a reliable
alternative, mainly in young people, which can achieve long-
term survival provided that certain requirements are met:
good design selection, sound choice of bearing surfaces based
on patient life expectancy,meticulous surgical technique, and
indications based on adequate bone quality.
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